Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

Disclaimer: This platform provides information and recommendations for educational purposes only and is not a substitute for professional financial advice. Our content covers a range of investment classes, including stocks and cryptocurrencies, and we do not guarantee the completeness, accuracy, reliability, or suitability of this information, which may include data from third-party services and content generated by artificial intelligence (AI). Investing in stocks, cryptocurrencies, and other financial instruments involves risks, including the potential loss of principal. Users should independently verify all information and seek advice from qualified professionals tailored to their individual financial situations and investment objectives. Our content and services are provided "as is" without any warranties, express or implied. We are not liable for any losses or damages arising from the use of our services. This disclaimer is subject to change; users are advised to review it periodically. Usage of our services constitutes acceptance of these terms.

Conmed

🇺🇸 NYSE:CNMD

View Company

Overview Earnings Dividends

Oct 28, 2020

•

Sep 30, 2020

Conmed Q3 2020 Earnings Report

Announced third quarter results, demonstrating commitment to operational execution amidst the global COVID-19 environment.

Key Takeaways

CONMED Corporation reported its third quarter results, highlighting the team's commitment to operational execution despite ongoing geographic variability in procedure volumes due to the COVID-19 pandemic. The company remains confident in achieving profitable above-market growth over the long term.

Generated continued positive momentum within the business.

Experienced ongoing geographic variability in procedure volumes.

Demonstrated outstanding commitment to serving customers.

Maintained continued expense discipline.

Total Revenue

$238M

Previous year: $234M

+1.8%

EPS

$0.88

Previous year: $0.62

+41.9%

Gross Profit

$134M

Previous year: $130M

+2.8%

Cash and Equivalents

$35.6M

Previous year: $30.1M

+18.4%

Free Cash Flow

$31.8M

Previous year: $31.7M

+0.3%

Total Assets

$1.74B

Previous year: $1.76B

-0.9%

Conmed

Forward Guidance

Due to the continued uncertainty created by the COVID-19 pandemic, management is unable to provide financial guidance at this time.

Company Overview

Full financial data and analysis

View Conmed